Maverick Ventures

Maverick Ventures is a venture capital firm based in San Francisco, California, and serves as the venture arm of Maverick Capital, which was founded in 2015. The firm focuses on providing growth capital to early-stage companies across several sectors, including healthcare, technology, and consumer products. Within healthcare, Maverick Ventures invests in areas such as software services, medical devices, diagnostics, and biotechnology. In the technology and consumer sectors, it emphasizes various business models like online and mobile-first approaches. The firm operates with an evergreen investment structure, enabling it to support entrepreneurs over an extended period. By leveraging its agile team and the resources of a multi-billion dollar fund, Maverick Ventures aims to foster innovation and growth in its portfolio companies.

Ambar Bhattacharyya

Managing Director

Suzanne Guthrie

CFO

Andrew Homan

Managing Director

Prateesh Maheshwari

Managing Director

David Singer

Investor

Soren Sudhof

Managing Director

188 past transactions

CareHarmony

Series A in 2022
At CareHarmony, we seek to improve the patient experience and clinical outcomes by providing compassionate, whole-person care coordination services. Our high-tech, high-touch offering includes a turnkey Chronic Care Management solution designed to offer healthcare providers an easy, limited-risk first step into value-based care.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Proximie

Series C in 2022
Proximie Inc., based in Bedford, Massachusetts, offers a secure software platform that facilitates virtual surgical collaboration among surgeons. By leveraging advanced telecommunication, augmented reality, artificial intelligence, and machine learning technologies, Proximie's platform enables real-time, peer-to-peer assistance during surgeries, regardless of location. This innovative approach allows surgeons to share expertise before, during, and after procedures, effectively overcoming the barriers of time and distance. Furthermore, the platform is compatible with various devices and software used in operating rooms, allowing for seamless integration and interaction. Proximie's mission is to enhance surgical knowledge and skills, enabling surgeons to refine their techniques in diverse settings, even with limited bandwidth.

Coherent

Series B in 2022
Coherent is a technology company that specializes in providing software solutions for the insurance industry. Founded in 2018 and headquartered in Causeway Bay, Hong Kong, with additional offices in Shanghai, Singapore, and Manila, Coherent develops applications that enhance product development, sales, and customer engagement for insurance companies. Its flagship offerings include Factory, a tool enabling insurers to digitize backend operations and manage pricing models through Excel; Coherent Connect, a social media marketing campaign manager; Coherent Explainer, which simplifies the quote breakdown process; and Coherent Flow, designed for remote policy sales through features like video chat and electronic signatures. Additionally, the company offers Coherent Spark, a no-code platform that transforms spreadsheet-based business logic into customized APIs, facilitating better integration of software solutions across business operations.

D-ID

Series B in 2022
D-ID is a technology company that specializes in face recognition and de-identification solutions, catering to Fortune 500 companies and institutions globally. Founded in 2016 and based in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a suite of products designed to enhance identity protection and ensure compliance with regulations by eliminating sensitive biometric data from facial images. Their innovative technology can generate photos and videos that remain indistinguishable to the human eye while being unrecognizable to face recognition algorithms. This capability is crucial for organizations seeking to safeguard biometric databases and comply with privacy regulations. Additionally, D-ID leverages artificial intelligence to create personalized media for applications in e-learning, corporate training, and sales enablement, facilitating the development of AI-powered conversational agents and engaging video content.

PrognomIQ

Venture Round in 2022
Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. The company's products leverage proteomic data to complement extensive proteomic information with genomic, metabolomic and other health data and discover innovative approaches to early disease detection that translate into transformative test products, enabling medical practitioners to improve diagnostic tests and recurrence monitoring of critical diseases.

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on engineering and developing tools for biological automation. Founded in 2018, the company specializes in creating scalable automation solutions for genetic engineering, aiming to enhance efficiency and precision in biological research and applications.

FitOn

Series C in 2022
FitOn Inc. is a fitness technology company that has developed a mobile application designed to facilitate health and fitness goals through access to various workout classes. Launched in 2018 and headquartered in Los Angeles, California, the FitOn app offers users unlimited participation in live and on-demand classes across diverse fitness disciplines, including yoga, Pilates, cardio, dance, and barre, without the need for any equipment. Additionally, the platform features social elements that allow users to invite friends and engage with other participants while exercising. FitOn also includes tools for tracking calories, monitoring collective statistics, and sharing progress, enhancing the overall user experience and community engagement.

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Clari

Series F in 2022
Clari Inc. operates a revenue operations platform designed to enhance the efficiency of sales professionals by integrating automation and AI with key business activity data. Founded in 2012 and based in Sunnyvale, California, Clari's platform enables sales teams to streamline deal closing, minimize manual reporting, and gain real-time insights into deal progress. By automatically aligning data from various sources such as CRM, marketing automation, email, and call systems, Clari provides visibility and predictive insights that help organizations make informed decisions and forecast revenue more accurately. Its platform is utilized by numerous B2B companies, including well-known brands, to manage pipelines, audit deals, and reduce customer churn, ultimately transforming revenue operations into a more connected and predictable process.

Chapter

Series B in 2022
Chapter is a New York-based company that specializes in providing Medicare advisory services to seniors. It offers personalized consultations to help retirees navigate their healthcare options, including guidance on medical services and recommended medical card programs. Chapter enhances the decision-making process for older adults by offering tailored coupons, deals, tax advice, and relevant news and technology tips. The company's goal is to empower seniors to make informed choices about their health coverage, enabling them to live with purpose and security as they age.

Belong Health

Series A in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.

Heap

Series D in 2021
Heap Inc. develops an analytics platform designed to enhance decision-making for online businesses by automating the collection and analysis of customer interaction data. Founded in 2012 and headquartered in San Francisco, California, with additional offices in New York and Utah, Heap's solution captures various user interactions, such as clicks, submissions, and transactions, without requiring extra coding. This enables companies across diverse sectors, including e-commerce, financial services, and SaaS, to gain comprehensive insights into customer behavior and improve their products and services. With a mission to empower businesses with accurate data, Heap serves over 6,000 clients, allowing them to focus on actionable insights and optimize conversion rates effectively.

FitOn

Series B in 2021
FitOn Inc. is a fitness technology company that has developed a mobile application designed to facilitate health and fitness goals through access to various workout classes. Launched in 2018 and headquartered in Los Angeles, California, the FitOn app offers users unlimited participation in live and on-demand classes across diverse fitness disciplines, including yoga, Pilates, cardio, dance, and barre, without the need for any equipment. Additionally, the platform features social elements that allow users to invite friends and engage with other participants while exercising. FitOn also includes tools for tracking calories, monitoring collective statistics, and sharing progress, enhancing the overall user experience and community engagement.

Devoted

Series D in 2021
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Devoted

Series D in 2021
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Centivo

Venture Round in 2021
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

Chapter

Series A in 2021
Chapter is a New York-based company that specializes in providing Medicare advisory services to seniors. It offers personalized consultations to help retirees navigate their healthcare options, including guidance on medical services and recommended medical card programs. Chapter enhances the decision-making process for older adults by offering tailored coupons, deals, tax advice, and relevant news and technology tips. The company's goal is to empower seniors to make informed choices about their health coverage, enabling them to live with purpose and security as they age.

Apna

Series C in 2021
Apna is a recruitment platform that gives opportunities for blue or grey collar jobs. The company works for those who require jobs and those who are looking for the best employees for their companies. It gives maximum opportunities through a single platform for the biggest job groups in India. The company was founded in 2019 and based in Bengaluru, Karnataka.

House Rx

Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

CCC Drive

Post in 2021
CCC Drive, based in Glen Allen, Virginia, provides a versatile technology platform for insurance telematics, known as DriveFactor. This platform allows for the integration of data from various sources and facilitates sharing with business partners. CCC Drive enables clients to manage the entire claims process, including intake, evaluation, settlement, and optimization. The company, originally founded in 2010 as DriveFactor Inc., became a subsidiary of CCC Information Services Inc. in 2015. CCC Information Services focuses on enhancing claims management through integrated solutions, offering advanced collision repair and insurance estimating software, analytical tools, and data services. Their technology improves efficiency across the claims management supply chain, fostering communication among a network of approximately 21,000 auto body collision repair facilities and 350 insurance companies.

Zus Health

Series A in 2021
Zus Health is a developer of a healthcare data platform designed to enhance digital health by facilitating the creation of customized technologies and services. The platform connects both health and non-health information, offering a comprehensive view of patients while allowing for the sharing of clinical and non-clinical data without the need for shared applications. By removing traditional barriers in healthcare technology development, Zus Health empowers healthcare professionals to develop solutions that are more affordable and tailored to individual needs, ultimately aiming to improve the overall healthcare experience.

Fractyl Health

Series F in 2021
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Belong Health

Seed Round in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.

CareMax

Post in 2021
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CarMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

Cano Health

Post in 2021
Cano Health is a rapidly expanding operator of healthcare centers that emphasizes "Primary Care Plus," aiming to enhance the health and well-being of individuals, families, and communities. The company provides comprehensive primary medical care alongside specialty programs in areas such as Venous Medicine, Arthritis, Allergy, and Weight Loss. With a focus on personalized, value-based care, Cano Health serves approximately 310,000 members through its advanced medical centers located in Miami-Dade and Broward counties. By leveraging technology and a high-touch approach, Cano Health seeks to transform healthcare delivery, improving the overall quality of life for its patients and the communities it serves.

QuintoAndar

Series E in 2021
QuintoAndar Serviços Imobiliários Ltda. is a Brazilian company that offers online services for property rental and sales, aiming to simplify the process for both landlords and renters. Founded in 2012 and headquartered in São Paulo, the company has expanded its presence with offices in multiple cities across Brazil, including Rio de Janeiro, Belo Horizonte, and Brasilia, among others. QuintoAndar leverages advanced practices and tools to enhance the rental experience, focusing on providing a streamlined and user-friendly platform. The company is known for its informal work environment and horizontal hierarchy, emphasizing autonomy and efficiency in decision-making. Through its innovative approach, QuintoAndar seeks to positively impact the lives of its customers by making real estate transactions more accessible and efficient.

SnapDocs

Series D in 2021
Snapdocs, Inc. is a real estate technology company that provides a digital platform designed to streamline the mortgage closing process. Founded in 2012 and based in San Francisco, California, Snapdocs connects lenders, title and escrow companies, notary publics, and home buyers to enhance collaboration and efficiency in real estate transactions. The platform features advanced automation and standardized workflows, allowing participants to choose their preferred closing methods while improving accuracy and consumer satisfaction. It also enables notary signing agents to showcase their qualifications, helping them attract potential clients. By simplifying mortgage loan closings and improving the overall borrower experience, Snapdocs empowers its users to operate more effectively and transparently in a competitive market.

Infleqtion

Convertible Note in 2021
Infleqtion, previously known as ColdQuanta, develops and designs instruments and systems for quantum technology applications. The company offers a range of products, including cold atom systems, ultra-cold atom systems, glass cells, and various electronic devices such as atom chip drivers and instrument control systems. These offerings cater to scientific and industrial applications, including cold atom information processing, atomic clocks, and inertial sensing. Infleqtion serves a diverse clientele, including commercial and defense companies, national laboratories, and major universities. Founded in 2007 and headquartered in Boulder, Colorado, the company also maintains additional offices in Madison, Wisconsin, and Oxford, United Kingdom.

Collective Health

Series F in 2021
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.

Proximie

Series B in 2021
Proximie Inc., based in Bedford, Massachusetts, offers a secure software platform that facilitates virtual surgical collaboration among surgeons. By leveraging advanced telecommunication, augmented reality, artificial intelligence, and machine learning technologies, Proximie's platform enables real-time, peer-to-peer assistance during surgeries, regardless of location. This innovative approach allows surgeons to share expertise before, during, and after procedures, effectively overcoming the barriers of time and distance. Furthermore, the platform is compatible with various devices and software used in operating rooms, allowing for seamless integration and interaction. Proximie's mission is to enhance surgical knowledge and skills, enabling surgeons to refine their techniques in diverse settings, even with limited bandwidth.

Carta Healthcare

Series A in 2021
Carta Healthcare, Inc. is a technology company that has developed a software-as-a-service platform to enhance the patient journey within hospitals by utilizing data from existing IT systems. Founded in 2016 and headquartered in San Mateo, California, Carta's platform aims to personalize care by identifying past patients with similar profiles and analyzing their experiences. By employing machine learning, the platform predicts potential bottlenecks, alerts facilities about recovery bed shortages, and forecasts the needs and expectations of current patients. Additionally, Carta combines artificial intelligence with skilled human expertise to improve the efficiency and quality of healthcare data management, ultimately enabling health systems to achieve more effective data abstraction.

KUDO

Series A in 2021
KUDO, Inc., also known as Kudo Technologies, is a New York-based company that specializes in a multilingual online meetings platform. Founded in 2016, KUDO offers a language as a service (LaaS) and software as a service (SaaS) solution designed to facilitate global communication. The platform enables video conferencing with integrated support for interpreters and multiple audio streams, making it easier for teams and businesses to engage with diverse audiences. KUDO's offerings include multilingual live events, web conferencing, and language-ready tools that can be embedded into existing systems. The platform is accessible from standard computers and smartphones, allowing participants and interpreters to connect from anywhere in the world, thereby enhancing the ability of organizations to communicate effectively in multiple languages.

Cityblock

Series C in 2021
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Cylera

Series A in 2021
Cylera, Inc., founded in 2017 and based in New York, provides cybersecurity solutions specifically designed for healthcare organizations. The company focuses on protecting patients and healthcare providers from cyber threats, including malware. Its centralized cybersecurity software offers a comprehensive platform that identifies and assesses risks across various devices, such as medical equipment, operational technology, and enterprise IoT. By employing a patient-centric approach, Cylera enables healthcare institutions to detect threats and respond to them in real-time, ensuring the security and integrity of critical healthcare operations.

Caribou Biosciences

Series C in 2021
Caribou Biosciences, Inc. is a biotechnology company based in Berkeley, California, specializing in cellular engineering and genome analysis through CRISPR-Cas9 technology. Founded in 2011, the company provides a gene editing platform that allows for targeted modifications in the genome. Its applications span various sectors, including human and animal therapeutics, agricultural biotechnology, and industrial biotechnology. Caribou's solutions facilitate the development of new disease models, enhance traits in plants, and support functional genomic screens. The company aims to advance both basic and applied biological research, leveraging its transformative capabilities to impact therapeutic development and bioproduction.

Garner

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Cityblock

Series C in 2020
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Centivo

Series B in 2020
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

Infleqtion

Series A in 2020
Infleqtion, previously known as ColdQuanta, develops and designs instruments and systems for quantum technology applications. The company offers a range of products, including cold atom systems, ultra-cold atom systems, glass cells, and various electronic devices such as atom chip drivers and instrument control systems. These offerings cater to scientific and industrial applications, including cold atom information processing, atomic clocks, and inertial sensing. Infleqtion serves a diverse clientele, including commercial and defense companies, national laboratories, and major universities. Founded in 2007 and headquartered in Boulder, Colorado, the company also maintains additional offices in Madison, Wisconsin, and Oxford, United Kingdom.

Dewpoint Therapeutics

Series B in 2020
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Galecto

Series D in 2020
Galecto, Inc. is a clinical-stage biotechnology company founded in 2011, focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company leverages over a decade of research on the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic processes. Its therapeutic approach includes small-molecule inhibitors targeting these proteins. Galecto's leading product candidate, GB0139, is aimed at treating severe fibrotic lung diseases, notably idiopathic pulmonary fibrosis, while another candidate, GB1211, is a selective oral galectin-3 inhibitor intended for managing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto is positioned to address critical unmet medical needs in the treatment of fibrotic and related diseases.

PrognomIQ

Venture Round in 2020
Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. The company's products leverage proteomic data to complement extensive proteomic information with genomic, metabolomic and other health data and discover innovative approaches to early disease detection that translate into transformative test products, enabling medical practitioners to improve diagnostic tests and recurrence monitoring of critical diseases.

Orasis Pharmaceuticals

Series C in 2020
Orasis Pharmaceuticals Ltd is focused on developing innovative treatments for presbyopia, a common age-related vision condition. Founded in 2015 and based in Herzliya, Israel, the company has developed CSF-1, a corrective eye drop designed to improve near visual acuity through pupil modulation. This product aims to enhance the quality of life for individuals with presbyopia by alleviating the need for reading glasses. CSF-1 repurposes existing, well-studied molecules to ensure its effectiveness while prioritizing safety, comfort, and ease of use for patients. By providing a noninvasive treatment option, Orasis Pharmaceuticals offers a promising solution for those struggling with the symptoms of presbyopia.

Decent

Series A in 2020
Decent Inc. is a healthcare insurance provider based in Mill Valley, California, founded in 2018. The company specializes in offering health and medical insurance plans tailored for self-employed professionals, notably the Trailblazer Plan, which is designed to meet the unique needs of freelance workers. Decent aims to make healthcare more affordable by aligning incentives to enhance health outcomes and lower costs. Utilizing innovative technologies such as cryptocurrency and blockchain, Decent's platform facilitates access to a range of insurance options while partnering with a network of healthcare providers, including doctors, hospitals, and specialists. This approach places members at the center of their care, promoting better health management and financial savings.

Octopai

Series A in 2020
Octopai B.I. Ltd. is a company based in Rosh Haayin, Israel, that specializes in developing automated, centralized solutions for managing business intelligence (BI) and IT systems. Their flagship product, Total Impact, serves as an impact analysis tool and cross-platform navigator, allowing users to effectively navigate through ETL tools, data warehouses, and reporting tools. By providing a centralized metadata search engine, Octopai enables BI teams to quickly discover and govern shared metadata, enhancing productivity and reducing the risks associated with inaccurate data. Founded in 2015 by former BI leaders who experienced the challenges of siloed tools, Octopai aims to alleviate the complexities of data management, facilitating automated data lineage, discovery, and cataloging while streamlining system replacements and development processes.

Seer

Series D in 2020
Seer, Inc. is a life sciences company that specializes in developing nanoparticle technology solutions aimed at advancing proteomics research. The company's flagship product, Proteograph, is an integrated system that includes consumables, automation instrumentation, and proprietary software designed for proteomics analysis. Seer targets academic institutions, life sciences research laboratories, and biopharmaceutical companies, offering its products for research purposes, specifically for non-diagnostic and non-clinical applications. Additionally, Seer has created a health data platform that enhances the early detection of chronic, life-threatening diseases by capturing and translating molecular insights from the proteome. This innovation aims to improve accuracy and speed in identifying conditions such as cancer and neurological diseases, ultimately facilitating earlier treatment and better patient outcomes. Headquartered in Redwood City, California, Seer was incorporated in 2017 and was previously known as Seer Biosciences, Inc. before its name change in July 2018.

Cityblock

Series B in 2020
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Behalf

Series D in 2020
Behalf, Inc. operates as a financing provider which facilitates commerce between business to business merchants and their business customers. The company allows merchant partners to offer business customers instant credit and flexible payment terms at the point of sale. It also provides working capital solutions for small businesses and flexible financing for business purchases. Behalf, Inc. was founded in 2011 and is headquartered in New York, New York. The company has additional offices in Tel Aviv, Israel

D-ID

Series A in 2020
D-ID is a technology company that specializes in face recognition and de-identification solutions, catering to Fortune 500 companies and institutions globally. Founded in 2016 and based in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a suite of products designed to enhance identity protection and ensure compliance with regulations by eliminating sensitive biometric data from facial images. Their innovative technology can generate photos and videos that remain indistinguishable to the human eye while being unrecognizable to face recognition algorithms. This capability is crucial for organizations seeking to safeguard biometric databases and comply with privacy regulations. Additionally, D-ID leverages artificial intelligence to create personalized media for applications in e-learning, corporate training, and sales enablement, facilitating the development of AI-powered conversational agents and engaging video content.

BioCatch

Series C in 2020
BioCatch is a Boston-based company that specializes in behavioral authentication and threat detection solutions for web and mobile applications. Founded in 2011, it utilizes advanced cognitive science and machine learning to analyze over 2,000 cognitive parameters, creating unique user profiles. The platform is designed to continuously authenticate users throughout their online sessions, effectively safeguarding against cyber threats and fraudulent activities such as account takeovers and automated account manipulation. BioCatch's behavioral biometrics technology identifies potentially risky digital behaviors and sophisticated social engineering scams, helping organizations, particularly banks, enhance fraud detection while minimizing friction during the digital user journey. This approach enables a secure and seamless experience for users, reinforcing identity and trust without compromising privacy.

Revuze

Series A in 2020
Revuze is experts in marketing, business development, product management and enterprise solutions. The Revuze leadership team brings broad and multidisciplinary experience in big data, machine learning, NLP (natural language processing) and sentiment analysis.

ConcertAI

Series B in 2020
ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients. It was incorporated in 2018 and is based in Boston, Massachusetts.

Bounce

Series D in 2020
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.

Seer

Series D in 2019
Seer, Inc. is a life sciences company that specializes in developing nanoparticle technology solutions aimed at advancing proteomics research. The company's flagship product, Proteograph, is an integrated system that includes consumables, automation instrumentation, and proprietary software designed for proteomics analysis. Seer targets academic institutions, life sciences research laboratories, and biopharmaceutical companies, offering its products for research purposes, specifically for non-diagnostic and non-clinical applications. Additionally, Seer has created a health data platform that enhances the early detection of chronic, life-threatening diseases by capturing and translating molecular insights from the proteome. This innovation aims to improve accuracy and speed in identifying conditions such as cancer and neurological diseases, ultimately facilitating earlier treatment and better patient outcomes. Headquartered in Redwood City, California, Seer was incorporated in 2017 and was previously known as Seer Biosciences, Inc. before its name change in July 2018.

Infleqtion

Seed Round in 2019
Infleqtion, previously known as ColdQuanta, develops and designs instruments and systems for quantum technology applications. The company offers a range of products, including cold atom systems, ultra-cold atom systems, glass cells, and various electronic devices such as atom chip drivers and instrument control systems. These offerings cater to scientific and industrial applications, including cold atom information processing, atomic clocks, and inertial sensing. Infleqtion serves a diverse clientele, including commercial and defense companies, national laboratories, and major universities. Founded in 2007 and headquartered in Boulder, Colorado, the company also maintains additional offices in Madison, Wisconsin, and Oxford, United Kingdom.

Remrise

Seed Round in 2019
Remrise, Inc. is a health and wellness company focused on enhancing sleep through personalized, plant-based supplements. Founded in 2018 and based in San Francisco, Remrise offers a unique approach by utilizing a quiz to identify individual sleep issues, allowing for the creation of customized formulas. These formulas are composed of drug-free ingredients, including Reishi, Spine Date Seed, and L-Theanine, which aim to improve sleep cycles without causing grogginess. In addition to its personalized supplements, Remrise provides a digital platform for users to track their sleep and wellness progress, fostering a holistic approach to better sleep habits and overall health.

Bungalow

Series B in 2019
Bungalow is a residential real estate platform that offers flexible communal living solutions for early career professionals. Founded in 2016 and based in San Francisco, the company transforms unused spaces into rentable rooms by signing long-term leases with homeowners. Bungalow provides fully furnished multi-bedroom homes in desirable neighborhoods across major U.S. cities, including Baltimore, New York City, and Los Angeles. Each home features private bedrooms, shared living spaces, and amenities such as Wi-Fi, utilities, and housekeeping services. In addition, Bungalow facilitates roommate matching to create harmonious living arrangements and organizes monthly community events to foster social connections among residents. The company aims to enhance the rental experience by providing high-quality homes and a supportive community for its members.

HumanFirst

Seed Round in 2019
HumanFirst, formerly known as Elektra Labs, is a healthcare-security company based in Tyngsboro, Massachusetts, that focuses on enhancing healthcare operations in home settings. Established in 2017, the company has developed a digital measures platform called Atlas, which streamlines the evaluation and implementation of connected technologies for collecting behavioral and physiological data. HumanFirst caters to a diverse clientele, including leading organizations involved in decentralized clinical trials and virtual care. Notably, 22 of the 25 largest pharmaceutical companies globally have utilized the HumanFirst platform to assess and facilitate the deployment of health technology products. The company provides command center and infrastructure solutions that ensure the reliability and trustworthiness of telehealth operations, matching the standards typically found in hospitals and laboratories.

Science Exchange

Venture Round in 2019
Science Exchange, Inc. operates an online marketplace designed to facilitate collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and headquartered in Palo Alto, California, the platform allows researchers to search for scientific services, compare pricing, and access quality testimonials, streamlining the procurement process. Additionally, Science Exchange offers an enterprise dynamic report tool that helps pharmaceutical and biotechnology companies track key performance indicators related to their outsourced research and development investments. By automating various collaborative tasks such as obtaining quotes, managing projects, and processing payments, the marketplace enhances R&D productivity while ensuring data security and regulatory compliance.

Science Exchange

Debt Financing in 2019
Science Exchange, Inc. operates an online marketplace designed to facilitate collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and headquartered in Palo Alto, California, the platform allows researchers to search for scientific services, compare pricing, and access quality testimonials, streamlining the procurement process. Additionally, Science Exchange offers an enterprise dynamic report tool that helps pharmaceutical and biotechnology companies track key performance indicators related to their outsourced research and development investments. By automating various collaborative tasks such as obtaining quotes, managing projects, and processing payments, the marketplace enhances R&D productivity while ensuring data security and regulatory compliance.

Mon Ami

Seed Round in 2019
Mon Ami, Inc. is a company based in Palo Alto, California, that connects college students with seniors who may be experiencing social isolation due to conditions such as dementia, Alzheimer's, Parkinson’s disease, autism, and cancer. Founded in 2018, Mon Ami offers an application that facilitates meetings between these individuals and their families, enhancing engagement and companionship. The company employs college students as "Activity Companions" who visit seniors in their homes to participate in tailored activities, including memoir-writing, art, and music, thereby fostering joy and connection. In addition to its core services, Mon Ami also develops specialized tools for aging and disability service providers, ensuring compliance with privacy regulations and streamlining operational processes.

Mon Ami

Seed Round in 2019
Mon Ami, Inc. is a company based in Palo Alto, California, that connects college students with seniors who may be experiencing social isolation due to conditions such as dementia, Alzheimer's, Parkinson’s disease, autism, and cancer. Founded in 2018, Mon Ami offers an application that facilitates meetings between these individuals and their families, enhancing engagement and companionship. The company employs college students as "Activity Companions" who visit seniors in their homes to participate in tailored activities, including memoir-writing, art, and music, thereby fostering joy and connection. In addition to its core services, Mon Ami also develops specialized tools for aging and disability service providers, ensuring compliance with privacy regulations and streamlining operational processes.

Heap

Series C in 2019
Heap Inc. develops an analytics platform designed to enhance decision-making for online businesses by automating the collection and analysis of customer interaction data. Founded in 2012 and headquartered in San Francisco, California, with additional offices in New York and Utah, Heap's solution captures various user interactions, such as clicks, submissions, and transactions, without requiring extra coding. This enables companies across diverse sectors, including e-commerce, financial services, and SaaS, to gain comprehensive insights into customer behavior and improve their products and services. With a mission to empower businesses with accurate data, Heap serves over 6,000 clients, allowing them to focus on actionable insights and optimize conversion rates effectively.

Seer

Series C in 2019
Seer, Inc. is a life sciences company that specializes in developing nanoparticle technology solutions aimed at advancing proteomics research. The company's flagship product, Proteograph, is an integrated system that includes consumables, automation instrumentation, and proprietary software designed for proteomics analysis. Seer targets academic institutions, life sciences research laboratories, and biopharmaceutical companies, offering its products for research purposes, specifically for non-diagnostic and non-clinical applications. Additionally, Seer has created a health data platform that enhances the early detection of chronic, life-threatening diseases by capturing and translating molecular insights from the proteome. This innovation aims to improve accuracy and speed in identifying conditions such as cancer and neurological diseases, ultimately facilitating earlier treatment and better patient outcomes. Headquartered in Redwood City, California, Seer was incorporated in 2017 and was previously known as Seer Biosciences, Inc. before its name change in July 2018.

1mg

Series D in 2019
1mg is a digital consumer healthcare platform based in Gurgaon, Haryana, India, launched in 2015. It aims to make healthcare more accessible, understandable, and affordable for users. The platform allows individuals to find detailed information about medicines prescribed by doctors and purchase them directly. Users can search for medications based on ailments, drug classes, companies, and brands. Additionally, 1mg features a doctor platform designed to help users locate suitable healthcare professionals for their needs. The company also offers a diagnostics service that enhances transparency and cost-effectiveness for lab tests, empowering Indian consumers and caregivers to choose the right healthcare services at competitive prices.

Aptible

Series A in 2019
Aptible Inc. is a company that specializes in providing a security management platform designed to automate HIPAA compliance for web and mobile developers. Founded in 2013 and based in San Francisco, Aptible offers solutions such as Aptible Enclave, a Docker-based platform for secure deployment in private AWS environments, and Aptible Gridiron, which serves as a security management platform for cloud-based software engineering teams. Additionally, Aptible Comply focuses on compliance monitoring and workflow automation for B2B SaaS teams, helping automate various compliance standards including SOC 2, ISO 27001, HIPAA, GDPR, and CCPA. The company primarily caters to digital health enterprises and startups, enabling them to manage infrastructure and security complexities efficiently while scaling their operations.

Collective Health

Series E in 2019
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.

Bounce

Series C in 2019
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.

Cityblock

Series B in 2019
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Artemis Health

Series C in 2019
Artemis Health Inc. is a health data analytics company that specializes in providing self-insured employers with actionable insights into their employee benefit programs. Founded in 2013 and headquartered in Salt Lake City, Utah, the company offers a platform that helps employers identify issues within their benefits programs, pinpoint opportunities for improvement, and track the effectiveness of implemented solutions. By leveraging their own benefits data, employers can make informed decisions aimed at reducing healthcare expenditures while enhancing the quality of health and wellness coverage for their employees. Artemis Health's approach aims to address inefficiencies in the U.S. healthcare system, ultimately supporting organizations in optimizing their benefit offerings.

Hims

Series C in 2019
Hims, Inc. is an e-commerce brand focused on men's wellness, offering a range of products that address hair loss, sexual health, skincare, and oral care. The company collaborates with medical professionals to provide prescriptions for treatments such as Finasteride and Sildenafil through its online platform, enabling customers to receive diagnoses and treatments conveniently and at a lower cost. Founded in 2017 and based in San Francisco, Hims aims to fill the gap in the market for men's wellness products by providing straightforward solutions to common concerns. The company has also ventured into lifestyle products, including clothing and accessories. Hims was incubated by the venture-builder Atomic and has successfully secured significant funding to support its growth.

Better Life Partners

Venture Round in 2019
We provide high quality and personalized health care for vulnerable populations - on their terms, where they are at. We’ve built technology that allows us to dynamically customize individual care plans and ensure reliable care delivery at scale, through telehealth, community-based, and digital modalities. By tightly integrating and coordinating medical and behavioral care we deliver superior value to patients and managed care organizations.

Seer

Series B in 2018
Seer, Inc. is a life sciences company that specializes in developing nanoparticle technology solutions aimed at advancing proteomics research. The company's flagship product, Proteograph, is an integrated system that includes consumables, automation instrumentation, and proprietary software designed for proteomics analysis. Seer targets academic institutions, life sciences research laboratories, and biopharmaceutical companies, offering its products for research purposes, specifically for non-diagnostic and non-clinical applications. Additionally, Seer has created a health data platform that enhances the early detection of chronic, life-threatening diseases by capturing and translating molecular insights from the proteome. This innovation aims to improve accuracy and speed in identifying conditions such as cancer and neurological diseases, ultimately facilitating earlier treatment and better patient outcomes. Headquartered in Redwood City, California, Seer was incorporated in 2017 and was previously known as Seer Biosciences, Inc. before its name change in July 2018.

Titan

Seed Round in 2018
Whisker Technologies, Inc., doing business as Titan Invest, provides investment advisory services. It offers advice for individual investing and retirement. The company offers an Individual Retirement Accounts Platform, which offers actively managed portfolios. It also offers an application software that enable users to invest capital in a basket of quality stocks based on their risk tolerance. The company was incorporated in 2017 and is based in New York, New York.

Galecto

Series C in 2018
Galecto, Inc. is a clinical-stage biotechnology company founded in 2011, focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company leverages over a decade of research on the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic processes. Its therapeutic approach includes small-molecule inhibitors targeting these proteins. Galecto's leading product candidate, GB0139, is aimed at treating severe fibrotic lung diseases, notably idiopathic pulmonary fibrosis, while another candidate, GB1211, is a selective oral galectin-3 inhibitor intended for managing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto is positioned to address critical unmet medical needs in the treatment of fibrotic and related diseases.

D-ID

Convertible Note in 2018
D-ID is a technology company that specializes in face recognition and de-identification solutions, catering to Fortune 500 companies and institutions globally. Founded in 2016 and based in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a suite of products designed to enhance identity protection and ensure compliance with regulations by eliminating sensitive biometric data from facial images. Their innovative technology can generate photos and videos that remain indistinguishable to the human eye while being unrecognizable to face recognition algorithms. This capability is crucial for organizations seeking to safeguard biometric databases and comply with privacy regulations. Additionally, D-ID leverages artificial intelligence to create personalized media for applications in e-learning, corporate training, and sales enablement, facilitating the development of AI-powered conversational agents and engaging video content.

Devoted

Series B in 2018
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Devoted

Series B in 2018
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Notable

Series A in 2018
Notable is an AI-powered healthcare startup focused on enhancing physician-patient interactions by automating and digitizing the recording of medical visits. The company's platform utilizes natural language processing and voice recognition technology to automatically capture and structure conversations between doctors and patients, facilitating the seamless update of electronic health records. Additionally, Notable's system recommends appropriate billing codes, streamlining administrative tasks for healthcare providers. By improving the efficiency of these interactions, Notable aims to allow physicians to dedicate more time to patient care rather than paperwork.

Cylera

Seed Round in 2018
Cylera, Inc., founded in 2017 and based in New York, provides cybersecurity solutions specifically designed for healthcare organizations. The company focuses on protecting patients and healthcare providers from cyber threats, including malware. Its centralized cybersecurity software offers a comprehensive platform that identifies and assesses risks across various devices, such as medical equipment, operational technology, and enterprise IoT. By employing a patient-centric approach, Cylera enables healthcare institutions to detect threats and respond to them in real-time, ensuring the security and integrity of critical healthcare operations.

Infleqtion

Seed Round in 2018
Infleqtion, previously known as ColdQuanta, develops and designs instruments and systems for quantum technology applications. The company offers a range of products, including cold atom systems, ultra-cold atom systems, glass cells, and various electronic devices such as atom chip drivers and instrument control systems. These offerings cater to scientific and industrial applications, including cold atom information processing, atomic clocks, and inertial sensing. Infleqtion serves a diverse clientele, including commercial and defense companies, national laboratories, and major universities. Founded in 2007 and headquartered in Boulder, Colorado, the company also maintains additional offices in Madison, Wisconsin, and Oxford, United Kingdom.

Centivo

Series A in 2018
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

Hims

Series B in 2018
Hims, Inc. is an e-commerce brand focused on men's wellness, offering a range of products that address hair loss, sexual health, skincare, and oral care. The company collaborates with medical professionals to provide prescriptions for treatments such as Finasteride and Sildenafil through its online platform, enabling customers to receive diagnoses and treatments conveniently and at a lower cost. Founded in 2017 and based in San Francisco, Hims aims to fill the gap in the market for men's wellness products by providing straightforward solutions to common concerns. The company has also ventured into lifestyle products, including clothing and accessories. Hims was incubated by the venture-builder Atomic and has successfully secured significant funding to support its growth.

Notable

Seed Round in 2018
Notable is an AI-powered healthcare startup focused on enhancing physician-patient interactions by automating and digitizing the recording of medical visits. The company's platform utilizes natural language processing and voice recognition technology to automatically capture and structure conversations between doctors and patients, facilitating the seamless update of electronic health records. Additionally, Notable's system recommends appropriate billing codes, streamlining administrative tasks for healthcare providers. By improving the efficiency of these interactions, Notable aims to allow physicians to dedicate more time to patient care rather than paperwork.

DECENT

Seed Round in 2018
DECENT Foundation, founded in 2015 and headquartered in Geneva, Switzerland, is a non-profit organization that develops a blockchain-based content distribution platform known as DCore. This open-source blockchain is specifically designed for digital content distribution, serving various sectors including media and entertainment, gaming and esports, ticketing, energy, digital advertising, IoT, and aviation and military industries. DCore provides user-friendly software development kits that empower developers and businesses to create decentralized applications and enterprise solutions. The platform is recognized for its stability, customization capabilities, and cost-effectiveness, making it a key player in facilitating efficient and distributed systems. DECENT has established a global presence with additional offices in regions such as the Slovak Republic, China, the United States, Korea, Singapore, Hong Kong, and Indonesia, and it collaborates closely with investment funds and incubators to foster a robust ecosystem around its blockchain technology.

BioCatch

Series B in 2018
BioCatch is a Boston-based company that specializes in behavioral authentication and threat detection solutions for web and mobile applications. Founded in 2011, it utilizes advanced cognitive science and machine learning to analyze over 2,000 cognitive parameters, creating unique user profiles. The platform is designed to continuously authenticate users throughout their online sessions, effectively safeguarding against cyber threats and fraudulent activities such as account takeovers and automated account manipulation. BioCatch's behavioral biometrics technology identifies potentially risky digital behaviors and sophisticated social engineering scams, helping organizations, particularly banks, enhance fraud detection while minimizing friction during the digital user journey. This approach enables a secure and seamless experience for users, reinforcing identity and trust without compromising privacy.

1mg

Series C in 2018
1mg is a digital consumer healthcare platform based in Gurgaon, Haryana, India, launched in 2015. It aims to make healthcare more accessible, understandable, and affordable for users. The platform allows individuals to find detailed information about medicines prescribed by doctors and purchase them directly. Users can search for medications based on ailments, drug classes, companies, and brands. Additionally, 1mg features a doctor platform designed to help users locate suitable healthcare professionals for their needs. The company also offers a diagnostics service that enhances transparency and cost-effectiveness for lab tests, empowering Indian consumers and caregivers to choose the right healthcare services at competitive prices.

D-ID

Seed Round in 2018
D-ID is a technology company that specializes in face recognition and de-identification solutions, catering to Fortune 500 companies and institutions globally. Founded in 2016 and based in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a suite of products designed to enhance identity protection and ensure compliance with regulations by eliminating sensitive biometric data from facial images. Their innovative technology can generate photos and videos that remain indistinguishable to the human eye while being unrecognizable to face recognition algorithms. This capability is crucial for organizations seeking to safeguard biometric databases and comply with privacy regulations. Additionally, D-ID leverages artificial intelligence to create personalized media for applications in e-learning, corporate training, and sales enablement, facilitating the development of AI-powered conversational agents and engaging video content.

Cityblock

Series A in 2018
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Notable

Seed Round in 2017
Notable is an AI-powered healthcare startup focused on enhancing physician-patient interactions by automating and digitizing the recording of medical visits. The company's platform utilizes natural language processing and voice recognition technology to automatically capture and structure conversations between doctors and patients, facilitating the seamless update of electronic health records. Additionally, Notable's system recommends appropriate billing codes, streamlining administrative tasks for healthcare providers. By improving the efficiency of these interactions, Notable aims to allow physicians to dedicate more time to patient care rather than paperwork.

Seer

Series A in 2017
Seer, Inc. is a life sciences company that specializes in developing nanoparticle technology solutions aimed at advancing proteomics research. The company's flagship product, Proteograph, is an integrated system that includes consumables, automation instrumentation, and proprietary software designed for proteomics analysis. Seer targets academic institutions, life sciences research laboratories, and biopharmaceutical companies, offering its products for research purposes, specifically for non-diagnostic and non-clinical applications. Additionally, Seer has created a health data platform that enhances the early detection of chronic, life-threatening diseases by capturing and translating molecular insights from the proteome. This innovation aims to improve accuracy and speed in identifying conditions such as cancer and neurological diseases, ultimately facilitating earlier treatment and better patient outcomes. Headquartered in Redwood City, California, Seer was incorporated in 2017 and was previously known as Seer Biosciences, Inc. before its name change in July 2018.

Valor Performance

Seed Round in 2017
Valor Performance is digital learning platform focused on igniting and sustaining peak performance for managers and executives. Valor closes the professional training gap through a dynamic digital platform, progress metrics, and personalized programs for all Valor recipients – giving them a premium experience while fostering a performance mindset. Founded in 2017, Valor Performance is headquartered in Boston, Massachusetts.

Collective Medical

Series A in 2017
Collective Medical Technologies, Inc. is a health care technology company that specializes in a real-time collaboration software platform designed to enhance patient care. Founded in 2005 and based in Cottonwood Heights, Utah, the platform connects a patient's entire care team, including hospitals, primary and secondary clinics, health plans, and community organizations, facilitating the sharing of vital information. Collective Medical's system-agnostic platform is utilized by a nationwide network of health plans and providers to identify at-risk patients and encourage actionable collaboration among care teams. The platform aims to improve patient outcomes by reducing unnecessary emergency department visits and hospital readmissions, utilizing real-time data, risk analytics, and shared care guidelines to inform provider decision-making. As of December 30, 2020, Collective Medical operates as a subsidiary of PointClickCare Corp.

Hims

Series A in 2017
Hims, Inc. is an e-commerce brand focused on men's wellness, offering a range of products that address hair loss, sexual health, skincare, and oral care. The company collaborates with medical professionals to provide prescriptions for treatments such as Finasteride and Sildenafil through its online platform, enabling customers to receive diagnoses and treatments conveniently and at a lower cost. Founded in 2017 and based in San Francisco, Hims aims to fill the gap in the market for men's wellness products by providing straightforward solutions to common concerns. The company has also ventured into lifestyle products, including clothing and accessories. Hims was incubated by the venture-builder Atomic and has successfully secured significant funding to support its growth.

Devoted

Series A in 2017
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Valor Performance

Seed Round in 2017
Valor Performance is digital learning platform focused on igniting and sustaining peak performance for managers and executives. Valor closes the professional training gap through a dynamic digital platform, progress metrics, and personalized programs for all Valor recipients – giving them a premium experience while fostering a performance mindset. Founded in 2017, Valor Performance is headquartered in Boston, Massachusetts.

Artemis Health

Series B in 2017
Artemis Health Inc. is a health data analytics company that specializes in providing self-insured employers with actionable insights into their employee benefit programs. Founded in 2013 and headquartered in Salt Lake City, Utah, the company offers a platform that helps employers identify issues within their benefits programs, pinpoint opportunities for improvement, and track the effectiveness of implemented solutions. By leveraging their own benefits data, employers can make informed decisions aimed at reducing healthcare expenditures while enhancing the quality of health and wellness coverage for their employees. Artemis Health's approach aims to address inefficiencies in the U.S. healthcare system, ultimately supporting organizations in optimizing their benefit offerings.

Homology Medicines

Series B in 2017
Homology Medicines, Inc. is a genetic medicines company based in Bedford, Massachusetts, focused on improving the lives of patients with rare genetic diseases. The company employs a proprietary platform that utilizes human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to deliver genetic therapies in vivo, either through gene therapy or nuclease-free gene editing. This innovative approach allows for targeted treatment of various disease-relevant tissues, including the liver and central nervous system, through a single injection. Homology's lead product candidate, HMI-102, is currently in a Phase 1/2 clinical trial for treating phenylketonuria (PKU) in adults, while HMI-103 targets pediatric PKU patients, and HMI-202 is being developed for metachromatic leukodystrophy. Founded in 2015, Homology Medicines aims to address significant unmet medical needs by targeting the underlying causes of genetic disorders.

Artemis Health

Series B in 2017
Artemis Health Inc. is a health data analytics company that specializes in providing self-insured employers with actionable insights into their employee benefit programs. Founded in 2013 and headquartered in Salt Lake City, Utah, the company offers a platform that helps employers identify issues within their benefits programs, pinpoint opportunities for improvement, and track the effectiveness of implemented solutions. By leveraging their own benefits data, employers can make informed decisions aimed at reducing healthcare expenditures while enhancing the quality of health and wellness coverage for their employees. Artemis Health's approach aims to address inefficiencies in the U.S. healthcare system, ultimately supporting organizations in optimizing their benefit offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.